Comparator supply for NCT05675410
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Sponsor: National Cancer Institute (NCI) (NIH). Phase: PHASE3. Status: Recruiting. Countries: United States, Canada, Puerto Rico. Last update posted 2026-09-09.
Registry record: https://clinicaltrials.gov/study/NCT05675410.
Canadian-labelled brentuximab vedotin
1 marketed Canadian product(s) from 1 manufacturer(s) contain brentuximab vedotin. Available strengths: 50 MG. Because the comparator is registered in Canada, supply can be arranged without a Special Access request and with the Canadian label, package insert and lot documentation the protocol expects.
Canadian-labelled cyclophosphamide
10 marketed Canadian product(s) from 3 manufacturer(s) contain cyclophosphamide. Available strengths: 1000 MG, 200 MG, 2000 MG, 25 MG, 50 MG, 500 MG. Because the comparator is registered in Canada, supply can be arranged without a Special Access request and with the Canadian label, package insert and lot documentation the protocol expects.
Canadian-labelled cyclophosphamide monohydrate
10 marketed Canadian product(s) from 3 manufacturer(s) contain cyclophosphamide. Available strengths: 1000 MG, 200 MG, 2000 MG, 25 MG, 50 MG, 500 MG. Because the comparator is registered in Canada, supply can be arranged without a Special Access request and with the Canadian label, package insert and lot documentation the protocol expects.
Canadian-labelled dacarbazine
1 marketed Canadian product(s) from 1 manufacturer(s) contain dacarbazine. Available strengths: 600 MG. Because the comparator is registered in Canada, supply can be arranged without a Special Access request and with the Canadian label, package insert and lot documentation the protocol expects.
Canadian-labelled dacarbazine - dtic
1 marketed Canadian product(s) from 1 manufacturer(s) contain dacarbazine. Available strengths: 600 MG. Because the comparator is registered in Canada, supply can be arranged without a Special Access request and with the Canadian label, package insert and lot documentation the protocol expects.
Canadian-labelled doxorubicin hydrochloride
7 marketed Canadian product(s) from 5 manufacturer(s) contain doxorubicin hydrochloride. Available strengths: 150 MG, 2 MG, 50 MG. Because the comparator is registered in Canada, supply can be arranged without a Special Access request and with the Canadian label, package insert and lot documentation the protocol expects.
Canadian-labelled etoposide
3 marketed Canadian product(s) from 3 manufacturer(s) contain etoposide. Available strengths: 20 MG, 50 MG. Because the comparator is registered in Canada, supply can be arranged without a Special Access request and with the Canadian label, package insert and lot documentation the protocol expects.
Canadian-labelled etoposide phosphate
3 marketed Canadian product(s) from 3 manufacturer(s) contain etoposide. Available strengths: 20 MG, 50 MG. Because the comparator is registered in Canada, supply can be arranged without a Special Access request and with the Canadian label, package insert and lot documentation the protocol expects.
Canadian-labelled prednisolone
3 marketed Canadian product(s) from 3 manufacturer(s) contain prednisolone acetate. Available strengths: 1 %. Because the comparator is registered in Canada, supply can be arranged without a Special Access request and with the Canadian label, package insert and lot documentation the protocol expects.
Canadian-labelled prednisone
5 marketed Canadian product(s) from 3 manufacturer(s) contain prednisone. Available strengths: 1 MG, 5 MG, 50 MG. Because the comparator is registered in Canada, supply can be arranged without a Special Access request and with the Canadian label, package insert and lot documentation the protocol expects.
Canadian-labelled prednisone intensol
5 marketed Canadian product(s) from 3 manufacturer(s) contain prednisone. Available strengths: 1 MG, 5 MG, 50 MG. Because the comparator is registered in Canada, supply can be arranged without a Special Access request and with the Canadian label, package insert and lot documentation the protocol expects.
Canadian-labelled vinblastine sulfate
2 marketed Canadian product(s) from 2 manufacturer(s) contain vinblastine sulfate. Available strengths: 1 MG. Because the comparator is registered in Canada, supply can be arranged without a Special Access request and with the Canadian label, package insert and lot documentation the protocol expects.
Canadian-labelled vincristine sulfate
2 marketed Canadian product(s) from 2 manufacturer(s) contain vincristine sulfate. Available strengths: 1 MG. Because the comparator is registered in Canada, supply can be arranged without a Special Access request and with the Canadian label, package insert and lot documentation the protocol expects.
What we supply
- Canadian-labelled comparator sourced through licensed Canadian supply
- Certificate of Analysis for every batch
- Batch number and expiry documentation, with retained records
- Blinding-ready packaging and over-encapsulation on request
- 2–8 °C validated cold chain with temperature logging where required
- Health Canada Drug Establishment Licence #3-002896
Frequently asked questions
Can Nexara supply Canadian-labelled brentuximab vedotin as a trial comparator?
Yes. We source Canadian-marketed brentuximab vedotin under Health Canada Drug Establishment Licence #3-002896 and ship it with Certificate of Analysis, batch number and expiry documentation for use as a comparator or rescue supply in NCT05675410.
What documentation comes with each shipment?
Certificate of Analysis, manufacturer batch and expiry records, chain-of-custody documentation from the Canadian supply chain, and temperature records where cold chain applies. Blinding-ready packaging is available on request.
How long does comparator supply take?
Quotes are returned within one business day. Lead time depends on the presentation and the destination country's import route — typically 10 to 21 days once the importer's licence and any notification are in place.
Request comparator quote
Request comparator quote or call +1-431-588-9055.